Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.34 |
| ▸ | GBA1 | P04062 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.31 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.31 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.31 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.31 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.31 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.31 |
| ▸ | PYGL | P06737 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12083286 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL5594313 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL7772026 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL15145344 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL3748632 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL13969566 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL24246852 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL22640981 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL21479622 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR | |
| SCHEMBL14339490 | 1.00 | GBA2 (0.35) | GBA2LGALS3GBA1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10254278-B2 | Method and system for detection of natural high intensity sweeteners that contain hydroxyl groups | PURECIRCLE SDN BHD (MY) | 2019-04-09 | — | — | US | disclosed |
| EP-1115731-A2 | NOVEL PYRANOSES | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000014097-A2 | NOVEL PYRANOSES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2000-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10254278-B2 | Method and system for detection of natural high intensity sweeteners that contain hydroxyl groups | CD44, SI, FCGR1A | GBA2 2788/4885LGALS3 598/4885GBA1 1692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.